Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F1AL8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,702
Award facts
- Contract value 100% obligated
- $53,702.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Gemtesa 75 mg tablets (90-count) with a ceiling value of $53.7K. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999 through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications, vaccines, medical supplies, and other healthcare commodities to support military healthcare programs worldwide. The IDC structure allows efficient fulfillment of federal medical requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order is scheduled for completion by January 23, 2026.
Quick answers
Who was awarded contract SPE2DR26F1AL8?
SPE2DR26F1AL8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F1AL8 worth?
The government has obligated $53,702 on SPE2DR26F1AL8.
Is contract SPE2DR26F1AL8 an order under another contract?
Yes. SPE2DR26F1AL8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AL8 competed?
The extent of competition for SPE2DR26F1AL8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award